Skip to main content

Market Overview

Mid-Day Market Update: Crude Oil Down 1.5%; Proteostasis Therapeutics Shares Spike Higher


Midway through trading Tuesday, the Dow traded up 0.24 percent to 25,238.47 while the NASDAQ declined 0.09 percent to 7,581.83. The S&P also rose, gaining 0.11 percent to 2,786.16.

Leading and Lagging Sectors

On Tuesday, the non-cyclical consumer goods & services shares gained 0.43 percent.

In trading on Tuesday, energy shares fell 0.28 percent. Meanwhile, top losers in the sector included CGG SA (ADR) (NYSE: CGG), down 27 percent, and Zion Oil & Gas, Inc. (NASDAQ: ZN) down 9 percent.

Top Headline

Dicks Sporting Goods Inc (NYSE: DKS) posted upbeat earnings for its fourth quarter, while sales missed expectations. The company also disclosed that it will no longer provide quarterly guidance.

Adjusted earnings came in at $1.22 per share, beating estimates by 2 cents. The company’s sales came in at $2.66 billion, versus analysts’ estimates of 2.73 billion. Its same-store sales slipped 2.0 percent.

Equities Trading UP

Proteostasis Therapeutics Inc (NASDAQ: PTI) shares shot up 55 percent to $6.41 after the biopharmaceutical company that focuses on treating diseases caused by an imbalance in the proteostasis network announced an update. The company said the FDA granted a Breakthrough Therapy Designation for its PTI-428, a cystic fibrosis transmembrane conductance regulator (CFTR) amplifier.

Shares of Innovate Biopharmaceuticals Inc (NASDAQ: INNT) got a boost, shooting up 21 percent to $23.06. Innovate Biopharmaceuticals named Dr. June Almenoff as COO and Chief Medical Officer.

Bovie Medical Corporation (NYSE: BVX) shares were also up, gaining 26 percent to $2.91 following a fourth quarter earnings and sales beat.

Equities Trading DOWN

Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares dropped 22 percent to $8.64 after the company posted downbeat results for its fourth quarter.

Shares of CounterPath, Corp. (NASDAQ: CPAH) were down 19 percent to $3.76 after the company reported results for its third quarter.

Advaxis, Inc. (NASDAQ: ADXS) was down, falling around 18 percent to $1.82. Advaxis reported a Q1 loss of $0.49 per share and announced a clinical hold in axalimogene filolisbac Phase 1/2 combination study with AstraZeneca's IMFINZI.


In commodity news, oil traded down 1.5 percent to $60.45 while gold traded up 0.23 percent to $1,323.80.

Silver traded up 0.27 percent Tuesday to $16.58, while copper rose 0.42 percent to $3.137.


European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.36 percent, the Spanish Ibex Index rose 0.15 percent, while Italy’s FTSE MIB Index slipped 0.11 percent. Meanwhile the German DAX declined 0.62 percent, and the French CAC 40 fell 0.14 percent while U.K. shares fell 0.62 percent.


The NFIB small business optimism index increased 0.7 point to a reading of 107.6 in February.

The consumer price index increased 0.2 percent for February, versus economists’ expectations for a 0.2 percent growth.

The Johnson Redbook Retail Sales Index fell 0.3 percent during the first week of March versus February.


Related Articles (BVX + ADXS)

View Comments and Join the Discussion!

Posted-In: Mid-Day Market UpdateNews Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at